Congress passes legislation that will delay the start of the Radiation Oncology (RO) Advanced Payment Model; examining the newly identified variant of SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19); a study finds Hispanics and those without college degrees most subject to excess death during pandemic.
Yesterday, Congress passed legislation supported by the American Society for Radiation Oncology (ASTRO) that will delay the start of the Radiation Oncology Advanced Payment Model (RO Model) until January 1, 2022. Announced in a press release by ASTRO, the move was followed by an oversight letter led by US Representatives Brian Higgins, D-New York, and Mike Kelly, R-Pennsylvania, that was sent to HHS Secretary Alex Azar, which called for changes to the “flawed” RO Model. Moreover, the 16 US representatives involved in the letter are seeking for CMS to protect cancer patients’ access to radiation treatments by ameliorating deep reimbursement cuts for radiation oncology providers who are required to participate in the model.
The New York Times has highlighted information to know about a newly identified variant of SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19). Known as B.1.1.7, the variation has been said to be more contagious than more established variants, with initial studies convincing UK Prime Minister Boris Johnson to tighten restrictions over the holidays. Although a virus lineage becoming more common does not mean it is more transmissable, epidemiological evidence conducted in England suggests that the variant has an increased transmission rate of 50% to 70% compared with other variants in the United Kingdom.
In a study of pandemic deaths in California published yesterday in JAMA Internal Medicine, the highest excess mortality was found among older adults, black and Hispanic residents, and those without college degrees. According to CIDRAP, excess death rates for Hispanic residents and people without a high school degree more than tripled after statewide shelter-in-place orders were lifted, which ran from March 1 to May 9. In the reopening period of May 10 to August 22, excess deaths for Hispanics were 3.1 times greater than during the shutdown, and those with a high school degree exhibited 3.4-fold increases in excess death rates.
Mitigating Barriers to Cell and Gene Therapy Access
February 14th 2025Cell and gene therapies can be life-changing for patients with certain conditions, but the process of receiving them poses barriers for patients and caregivers that require multistakeholder solutions, according to a white paper from the National Pharmaceutical Council.
Read More
The Uncertain Road Ahead for Health Care After DEI Rollbacks
February 7th 2025The removal of FDA guidance on clinical trial diversity and related anti–diversity, equity, and inclusion (DEI) actions may hinder progress toward equitable health care, impacting workforce diversity, patient outcomes, and research.
Read More
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Study Suggests Postdischarge Care Needs Targeted, Multifaceted Approaches
January 15th 2025The findings challenge the effectiveness of these widely used transitional care interventions and suggest a need for more targeted, multifaceted approaches to address the needs of higher-risk patients.
Read More